RNLS and COVID-19: Taken together, regarding the pathophysiology of COVID-19, decreased renalase plasma levels may be a relevant pathogenic factor (or a biomarker) resulting in (or predicting) a poor outcome, or may be relevant to guide patients' management, and therapeutic approach.